Page 15 - Affinity Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioAffinity Technologies today announced it appointed Michael Dougherty as chief financial officer, effective immediately.

BioAffinity Technologies (NASDAQ:BIAF – Get Rating) and iSpecimen (NASDAQ:ISPC – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Profitability This table compares bioAffinity Technologies and iSpecimen’s net margins, […]

31.03.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and 12 months ended ...

Conference Call Scheduled for April 3, 2023, at 9:00 a.m. Eastern Time ... | March 31, 2023

BioAffinity Technologies, Inc. today announced the publication of a paper titled “Porphyrin-modified beads for use as compensation controls in flow cytometry” in the peer-reviewed... | March 28, 2023